The market size for Aptamers at a worldwide level is estimated to value USD 207.7 million in 2020 and to grow USD 448.8 million by the end of 2025 with a growing potential of 16.66 % during the forecast period.
Aptamers are oligonucleotides that bind to a target protein, lipid, or nucleic acid molecules with high specificity. Aptamers are generated quickly and applied in the inhibition, characterization of proteins, and for specific detection and can be used as pharmaceutical leads, functional proteomic levels with antibodies, detection reagents, and small molecules. Aptamers can be engineered to have higher specificity and affinity for several targets.
The market's enormous opportunities for the key players are drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains, has recognized the potential of aptamers in diagnostics and therapeutics. So, the global market for aptamers is expected to grow, backed by technological advancements concerning selection processes and synthesis.
MARKET DRIVERS
The primary factors driving the growth of the market are technological advancements and increasing R & D investments in the pharmaceutical and biotechnology industries. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX) will positively boost this market.
Growing adoption of aptamers in chemical and food industries and increasing demand among the public for the aptamers due to benefits associated with it, such as their high efficiency and low cost compared to antibodies, are further expected to drive the global aptamers market.
MARKET RESTRAINTS
Stringent regulations in the use of aptamers, Ethical issues of the aptamers that are obtained from the animals, slow in reaching the market place owing to regulatory hurdles are hindering the growth of the market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analysed |
By Type, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global aptamers market has been segmented and sub-segmented based on the type, application, end-user, and region.
Aptamers Market - By Type:
Based on type, the DNA-based aptamers segment is dominating the global aptamer market concerning product type and is accounted for contributing a significant share of revenues to the market. This segment is likely to grow at an ample pace during the forecast period owing to increasing initiatives in research and developments on DNA-based aptamers.
Aptamers Market - By Application:
Based on the application, the Diagnostic segment has contributed a significant share of revenues to the aptamers market in the recent past. It is anticipated to be growing at a high pace due to a continually increasing population with various diseases leading to a boost in demand for different diagnostic techniques.
Aptamers Market - By End User:
Based on end-user, the academic and research institutes segment has contributed a significant share to the market in recent years. It is likely to grow further during the forecast period.
Aptamers Market - By Region:
Regionally, North America dominates the global Aptamers market with the highest share, followed by Europe, Asia - Pacific. Asia-Pacific is expected to account for the highest growth during the forecast period.
North America is leading the global aptamers market and is expected to continue growing throughout the forecast period. This region is strongly driven by factors such as advancements in technology and increasing R&D activities. The United States is playing a leading role in the North American market owing to the favorable government initiatives and a rising number of research laboratories.
The aptamers market in the European region is ranked as the second-largest region in the global market. The increasing number of approvals for existing advanced technologies, the rising occurrence rate of chronic diseases, and the growing demand for therapies of aptamers in Europe actively support market growth.
Growth of the aptamers market in the Asia-Pacific market is driven by the collective efforts by the key players of the developed regions to push into untapped markets. Increasing R & D investments in the pharmaceutical and biotechnology industries also bolstered the aptamers market growth during the forecast period.
Latin America, Middle East, and Africa regions are likely to have a stable growth rate during the forecast period.
TOP COMPANIES IN THE MARKET
Companies leading the global aptamers market profiled in the report are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd, Aptus Biotech S.L, Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc., TriLink BioTechnologies Inc., and Vivonics, Inc.
RECENT MARKET HAPPENINGS
In February 2019, the Base pair biotechnologies Inc. developed the point-of-care tests to diagnose neonatal abstinence syndrome based on aptamer with the assistance of the SBIR grant.
In January 2019, Aptamer Group announced that the AstraZeneca Company has agreed to collaborate with them to expand the aptamer technology application potential. With this collaboration, AstraZeneca will adapt to the technology developed by the aptamer group to improve the advanced drug delivery vehicles, which are named after Aptamer Drug Conjugates (ApDCs).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Peptide Aptamers
5.1.2 Nucleic Acid Aptamers
5.1.2.1 DNA-Based Aptamers
5.1.2.2 RNA-Based Aptamers
5.1.2.3 XNA-Based Aptamers
5.2 By Application
5.2.1 Therapeutics Development
5.2.2 Diagnostics
5.2.3 Research and Developments
5.3 By End Users
5.3.1 Pharmaceutical Companies
5.3.2 Bio-Pharmaceutical Companies
5.3.3 Academic and Research Centers
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 AM Biotechnologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Aptagen
8.3 Aptamer Sciences Inc.
8.4 Aptamer Solutions Ltd
8.5 Aptus Biotech S.L.
8.6 Base Pair Biotechnologies Inc
8.7 NeoVentures Biotechnology Inc.
8.8 SomaLogic Inc
8.9 TriLink BioTechnologies Inc
8.10 Vivonics, Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
